[Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC)].
Owada Y, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Muto S, Matsumura Y, Hasegawa T, Tanaka D, Kanno R, Ito E, Nanamiya H, Imai J, Isogai T, Watanabe S, Suzuki H.
Owada Y, et al. Among authors: suzuki h.
Gan To Kagaku Ryoho. 2017 Sep;44(9):763-766.
Gan To Kagaku Ryoho. 2017.
PMID: 28912405
Japanese.